NASDAQ:ABMD Abiomed - ABMD News Today Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Abiomed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Add Compare Share Share Today's Range$381.02▼$381.0250-Day Range$377.20▼$381.3052-Week Range$219.85▼$381.99Volume258 shsAverage Volume611,028 shsMarket Capitalization$17.18 billionP/E Ratio65.47Dividend YieldN/APrice Target$355.60 ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Get Abiomed News Delivered to You Automatically Sign up to receive the latest news and ratings for ABMD and its competitors with MarketBeat's FREE daily newsletter. Email Address ABMD Media Mentions By Week ABMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABMD News Sentiment▼0.440.34▲Average Medical News Sentiment ABMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABMD Articles This Week▼24▲ABMD Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineWant to Retire a Millionaire? 2 Stocks to Buy Nowstocknews.com - March 21 at 11:42 AM3 Stocks That Could Deliver Healthy Returns in 2023stocknews.com - March 17 at 5:31 PMThis Big Pharma Stock Is a Clear Buy in 2023stocknews.com - March 13 at 3:22 PMAbiomed, Inc. (ABMD) stock historical prices & data – Yahoo Financeuk.finance.yahoo.com - March 12 at 11:26 AM3 Powerhouse Stocks to Buy in 2023stocknews.com - March 10 at 9:22 AM3 Hot Dividend Stocks to Buy Now and Hold Foreverstocknews.com - March 6 at 4:53 PMAbiomed, Inc. (ABMD) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - March 4 at 6:21 PM2 No-Brainer Warren Buffett Stocks to Buy in 2023stocknews.com - March 2 at 11:58 AM3 S&P 500 Stocks to Buy If You Like Winningstocknews.com - March 1 at 12:37 PM3 Stocks to Help Grow Your Portfolio Over the Next Decadestocknews.com - February 28 at 2:37 PM3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfoliofinance.yahoo.com - December 22 at 1:25 PMFDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trialfinance.yahoo.com - December 21 at 9:08 AM10 Best Performing Stocks in Novemberfinance.yahoo.com - December 13 at 1:06 PMThis Monster Dividend Stock Isn't Done Growingfinance.yahoo.com - December 8 at 10:13 AMFirst Patients in the World Treated with Impella RP Flex with SmartAssistfinance.yahoo.com - December 5 at 6:10 PMWhy Is Abiomed (ABMD) Up 1.2% Since Last Earnings Report?finance.yahoo.com - December 1 at 5:43 PMJohnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomedfinance.yahoo.com - November 10 at 5:27 PMJohnson & Johnson's Big Purchase, Amazon's New Moves, and Morefinance.yahoo.com - November 5 at 12:41 PMAbiomed (ABMD) Q2 Earnings Top Estimates, Margins Downfinance.yahoo.com - November 1 at 2:39 PMIs Abiomed (ABMD) a Solid Growth Stock? 3 Reasons to Think "Yes"finance.yahoo.com - October 29 at 11:12 AMAbiomed Creates Patient Assistance Program to Address Disparities in Healthcarenz.finance.yahoo.com - October 26 at 8:49 AMVentricular Assist Devices Market Report (2022 to 2030) - Abiomed, Inc., Medtronic Plc, Abbott Laboratori - Benzingabenzinga.com - October 19 at 11:37 PMFDA Approves Abiomed's Impella Low Profile Sheathfinance.yahoo.com - October 17 at 9:11 PMAbiomed Announces U.S. FDA Grants 510(k) Clearance For Impella Low Profile Sheath - Abiomed (NASDAQ:ABMD) - Benzingabenzinga.com - October 17 at 10:07 AMAbiomed (ABMD) Announces U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath - StreetInsider.comstreetinsider.com - October 17 at 10:07 AMU.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheathfinance.yahoo.com - October 17 at 10:07 AMYale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support - Business Wirebusinesswire.com - October 13 at 3:15 PMAbiomed Second Quarter Fiscal 2023 Earnings and Conference Call Notification - Abiomed (NASDAQ:ABMD) - Benzingabenzinga.com - October 13 at 10:15 AMWalgreens (WBA) to Report Q4 Earnings: What's in the Cards? - Nasdaqnasdaq.com - October 10 at 2:22 PMAngioDynamics (ANGO) Q1 Earnings, Revenues Lag Estimates - Nasdaqnasdaq.com - October 10 at 2:22 PMAbiomed (ABMD) is an Incredible Growth Stock: 3 Reasons Why - Nasdaqnasdaq.com - October 7 at 8:39 PMHere's Why You Should Retain DENTSPLY SIRONA (XRAY) Stock Now - Nasdaqnasdaq.com - October 7 at 3:10 PMNeogen (NEOG) Q1 Earnings Top Estimates, Operating Margin Dips - Nasdaqnasdaq.com - October 7 at 3:10 PMEdwards Lifesciences (EW) TAVR Sales Strong Amid Macro Issues - Nasdaqnasdaq.com - October 7 at 3:10 PMAbiomed (ABMD) is an Incredible Growth Stock: 3 Reasons Whyfinance.yahoo.com - October 7 at 3:10 PMAbiomed, Inc. (NASDAQ:ABMD) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?nasdaq.com - September 28 at 3:16 PMMedical device maker Abiomed doubles revenue in five years - Boston Business Journal - The Business Journalsbizjournals.com - September 23 at 12:18 PMVentricular Assist Device Global Market Report 2022 - Yahoo Financefinance.yahoo.com - September 22 at 1:45 PMAbiomed (ABMD) Posts Impellas Positive Study Results in Japan - Nasdaqnasdaq.com - September 21 at 12:39 PMUnloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients - Business Wirebusinesswire.com - September 19 at 11:31 AMAbiomed (ABMD) Announces Large, Multi-Center, Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81% - StreetInsider.comstreetinsider.com - September 19 at 11:31 AMAbiomed (ABMD) Announces FDA Approval of RECOVER IV Trial with Exception from EFIC - StreetInsider.comstreetinsider.com - September 16 at 9:32 AMU.S. FDA gives two approvals to Abiomed Impella heart pumps - Seeking Alphaseekingalpha.com - September 16 at 9:32 AMFDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC)finance.yahoo.com - September 16 at 9:32 AMTCT 2022: Impella Enables Complete Revascularization, Improved Quality of Life and Native Heart Recovery - Business Wirebusinesswire.com - September 14 at 12:05 AMAbiomed (NASDAQ:ABMD) – TCT 2022: Impella Enables Complete Revascularization, Improved Quality of Life and Native Heart Recovery - Benzingabenzinga.com - September 13 at 8:54 AM3 Reasons to Hold Abiomed (ABMD) Stock in Your Portfolio - Nasdaqnasdaq.com - September 2 at 10:41 PM3 Reasons to Hold Abiomed (ABMD) Stock in Your Portfolio - Yahoo Financefinance.yahoo.com - September 2 at 5:39 PMMBTA Safety Report Reaction and Abiomed CEO - Bloombergbloomberg.com - September 1 at 2:42 AMTuesday Sector Leaders: Healthcare, Financial - Nasdaqnasdaq.com - August 31 at 6:40 AM Get Abiomed News Delivered to You Automatically Sign up to receive the latest news and ratings for ABMD and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:ABMD) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.